Aurora Spine (TSXV:ASG) NonCurrent Deferred Liabilities : C$0.00 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Aurora Spine's non-current deferred liabilities for the quarter that ended in Mar. 2025 was C$0.00 Mil.

Aurora Spine NonCurrent Deferred Liabilities Historical Data

The historical data trend for Aurora Spine's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine NonCurrent Deferred Liabilities Chart

Aurora Spine Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

Aurora Spine Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Aurora Spine NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Aurora Spine's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurora Spine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (TSXV:ASG) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

ASAPF:USA

Address

20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1

Website

https://www.aurora-spine.com

Aurora Spine Corp is engaged in the development, manufacture, and selling of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.

Executives

James Snow	Director
Trent James Northcutt	10% Security Holder, Director, Senior Officer
Chad Clouse	Senior Officer
Laszlo Garamszegi	Senior Officer
David Aubrey Rosenkrantz	Director